“The DOJ/FBI are investigating and the money has been frozen. It is insane that the Biden Admin would give $2B to an organization that previously only received $100!” A Stacey Abrams-linked ...

Homing in once again on the fractured Canada-U.S. relationship, Liberal Leader Mark Carney unveiled a $2-billion proposal to protect Canada's auto industry while in Windsor, Ont., on Wednesday ...

COOS BAY, Oregon — More than a dozen lumber mills once dotted the landscape around Coos Bay, a horseshoe-shaped estuary on Oregon’s remote southwest coast. Now, there is just one. The timber ...

Merck MRK announced that it has entered into an exclusive licensing deal with China-based Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma) for the latter’s investigational oral small-molecule ...

PHILADELPHIA (WPVI) -- The issue of affordable housing took center stage Monday at a first-of-its-kind meeting inside Philadelphia City Council chambers. The purpose of the special session was to ...

"Where is PNG headed? If the government continues down this path, it risks trading democracy for control." Many social media users, however, appeared to outdo the government, with many downloading and ...

Merck (MRK) has signed a licensing agreement for a heart disease drug developed by a Chinese company in a deal worth up to $2 billion, the latest in a series of cross-border deals between Western ...

The Federal Government has commenced the construction of Phase 2B of the access road to the Second Niger Bridge, marking a significant step in enhancing transportation infrastructure and regional ...

Because it's really the RMS Titanic. Sort of like how ships that have been commissioned for the United States Navy use the USS (United States Ship) prefix. In the grand scheme of things ...

Novo Nordisk and The United Bio-Technology (Hengqin) Co., Ltd. have entered into an exclusive license agreement for UBT251, a triple agonist of the receptors for GLP-1, GIP, and glucagon in ...

Unity Biotechnology announced topline results from its phase 2b ASPIRE clinical trial of intravitreal UBX1325 in patients with diabetic macular edema (DME) who had poor vision despite prior anti-VEGF ...